Cellectis (CLLS) FCF Margin (2015 - 2026)
Cellectis' (CLLS) quarterly FCF Margin came in at 262.16% in Q1 2026, down 10482.0% year-on-year from N/an in Q1 2025, and down 128.32% quarter-over-quarter from 114.82% in Q4 2025.
Cellectis (CLLS) FCF Margin (2015 - 2026) Analysis & Trends
Cellectis' FCF Margin history runs 12 years deep, the most recent figure standing at 262.16% for Q1 2026.
- On a quarterly basis, FCF Margin fell 10482.0% year-over-year to 262.16% in Q1 2026; TTM through Mar 2026 was 57.03%, a 11316.0% decrease from a year earlier, with the FY2025 full-year figure at 57.25%, down 10641.0% from the prior year.
- FCF Margin fell to 262.16% in Q1 2026 per CLLS's latest filing, from 114.82% in the prior quarter.
- Across five years, FCF Margin topped out at 12085.87% in Q4 2023 and bottomed at 18805.04% in Q1 2023.
- The 5-year median for FCF Margin is 157.34% (2025), against an average of 2564.21%.
- Across the five-year window, FCF Margin slumped 1705519 bps in 2023 and jumped 1829494 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 13.53% in 2022, then soared by 89428 bps to 12085.87% in 2023, then plunged by 100 bps to 36.67% in 2024, then slumped by 213 bps to 114.82% in 2025, then plunged by 128 bps to 262.16% in 2026.
- Per Business Quant, the three latest CLLS FCF Margin figures stand at 262.16% (Q1 2026), 114.82% (Q4 2025), and 1.11% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -262.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -262.16% |
| Dec 31, 2025 | -114.82% |
| Sep 30, 2025 | -1.11% |
| Jun 30, 2025 | -59.82% |
| Mar 31, 2025 | -157.34% |
| Dec 31, 2024 | -36.67% |
| Sep 30, 2024 | -31.19% |
| Jun 30, 2024 | 660.19% |
| Mar 31, 2024 | -510.09% |
| Dec 31, 2023 | 12,085.87% |
| Sep 30, 2023 | -10,825.81% |
| Jun 30, 2023 | -9,608.43% |
| Mar 31, 2023 | -18,805.04% |
| Dec 31, 2022 | -13.53% |
| Sep 30, 2022 | -12,820.00% |
| Jun 30, 2022 | -1,341.70% |
| Mar 31, 2022 | -1,749.85% |
| Dec 31, 2021 | -564.01% |
| Sep 30, 2021 | -310.55% |
| Jun 30, 2021 | -59.73% |